Inventor · Cambridge, MA, US

Satyanarayana Kuchimanchi

37Patents
7h-index
32Co-inventors
65Inventor score

Filing activity: Dec 16, 2010 → Jun 24, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9796974B2 Modified RNAi agents Chemistry; Metallurgy 85 Active
US9399775B2 RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases Chemistry; Metallurgy 29 Active
US9127274B2 Serpinc1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US9249415B2 Complement component C5 iRNA compositions and methods of use thereof Chemistry; Metallurgy 11 Active
US10238749B2 Angiotensinogen (AGT) iRNA compositions and methods of use thereof Chemistry; Metallurgy 8 Active
US10570391B2 RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases Chemistry; Metallurgy 8 Active
US10668170B2 Modified RNAi agents Chemistry; Metallurgy 8 Active
US9701963B2 Complement component C5 iRNA compositions and methods of use thereof Chemistry; Metallurgy 6 Active
US9376680B2 Serpinc1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8293718B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US8623838B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US9850488B2 Complement component C5 iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8481509B2 Organic compositions to treat HSF1-related diseases Chemistry; Metallurgy 5 Active
US11034958B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US10125369B2 PCSK9 iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US10407679B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US11406716B2 Modified RNAi agents Chemistry; Metallurgy 3 Active
US9068184B2 Compositions and methods for inhibition of expression of protein C (PROC) genes Chemistry; Metallurgy 3 Active
US10814007B2 Angiotensinogen (AGT) iRNA compositions and methods of use thereof Chemistry; Metallurgy 2 Active
US10287582B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 2 Active
US9970006B2 Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes Chemistry; Metallurgy 2 Active
US9540643B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 2 Active
US11142766B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 2 Active
US9096637B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 2 Active
US9725718B2 Compositions and methods for inhibition of expression of protein C (PROC) genes Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.